See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 6, 2010

Facial Acne HIV Migraine

(HealthDay News) -- Here are the latest clinical trials, courtesy of

Facial Acne

This study is for people aged 12 to 45 with moderate-to-severe facial acne. Participants may qualify for compensation up to $300.

The research site is in Bryan, Texas.

More information

Please see



This study will evaluate kd-247, a humanized monoclonal antibody, in people with HIV-1 infection who lack symptoms and are not receiving current antiretroviral therapy.

The research site is in Tamarac, Fla.

More information

Please see



This study will compare different FDA-approved treatment options for acute migraines.

The research site is in Charleston, S.C.

More information

Please see


Copyright 2010 All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.